Follicular lymphoma: open trials in Austria

• NCT06149286

  A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma

  Trial Treatment · Phase 3 · Regeneron Pharmaceuticals

  Ordensklinikum Linz GmbH, Linz · Kepler Universitaetsklinikum GmbH, Linz · Medical University of Vienna, Vienna · Klinikum Wels-Grieskirchen GmbH, Wels

  Registry updated 2026-10-07

• NCT06091254

  A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

  Trial Treatment · Phase 3 · Regeneron Pharmaceuticals

  Ordensklinikum Linz, Linz · Ordensklinikum Linz GmbH Elisabethinen, Linz · Uniklinikum Salzburg (LKH) Universitatsklinik fur Innere Medizin III, Salzburg · Hanusch-Krankenhaus, Vienna · Medical University of Vienna, Vienna

  Registry updated 2026-10-06

• NCT05326308

  Zanubrutinib in Patients With Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma and Follicular Lymphoma

  Research · iOMEDICO AG

  Universitätsklinikum Salzburg, Klinik für Innere Medizin III, Salzburg

  Registry updated 2026-09-09

• NCT04844866

  Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients

  Trial Treatment · Phase 2 · Miltenyi Biomedicine GmbH

  Medical University of Graz, Graz · Medizinische Universitaet Innsbruck, Innsbruck · Ordensklinikum Linz GmbH, Linz · Medical University of Vienna, Vienna

  Registry updated 2026-06-10

• NCT06830759

  Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma

  Research · AbbVie

  Krankenhaus Der Barmherzigen Brueder Graz /ID# 273288, Graz · Landeskrankenhaus Hochsteiermark, Standort Leoben /ID# 273266, Leoben

  Registry updated 2026-02-17

All Follicular lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error